ACT-HIB
Google image searchProduct monograph
Active ingredients
haemophilus influenzae type b-prp, 10 MCG/0.5 ML
tetanus protein, 30 MCG/0.5 ML
DIN: 01959034
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 14-JUL-2006
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AG — Hemophilus influenzae B vaccines (ATC, ATC/DDD)
- J07AG01 — HEMOPHILUS INFLUENZAE B, PURIFIED ANTIG. CONJUGATED (ATC/DDD)
Reference brand drug: Act-hib
